NCT04281485: A reported trial by Pfizer
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04281485 |
|---|---|
| Title | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF 06939926 FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 5, 2020 |
| Completion date | May 15, 2024 |
| Required reporting date | May 15, 2025, midnight |
| Actual reporting date | May 6, 2025 |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |